Back to top

Piper Sandler Keeps Their Buy Rating on Climb Bio (CLYM)

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Climb Bio, with a price target of $23.00. According to Tip...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Climb Bio, Inc. (CLYM)